Further re Transfer of Assets
27 May 2020
Circassia Group plc
Further re Proposed Transfer of Assets
Circassia Group plc ("Circassia" or "the Company") today announces that the mandatory 30 day waiting period for US anti-trust clearance expired at midnight on 26 May. Accordingly, the proposed transfer of the Tudorza and Duaklir assets to AstraZeneca first announced on 9 April 2020 is now expected to complete during the course of the next three days.
A further announcement will be made once completion has taken place.
-Ends-
For further information, please contact:
Circassia Group plc
Ian Johnson, Executive Chairman |
c/o Peel Hunt |
Michael Roller, CFO |
|
|
|
Peel Hunt (Nominated Adviser and Joint Broker) | Tel: +44 (0) 20 7418 8900 |
James Steel / Oliver Jackson |
|
|
|
finnCap (Joint Broker) | Tel: +44 (0) 20 7220 0500 |
Geoff Nash / Alice Lane |
|
|
|
Numis Securities (Joint Broker) | Tel: +44 (0) 20 7260 1000 |
James Black / Duncan Monteith |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.